KindlyMD (NASDAQ:NAKA) Stock Price Down 33.4% - Time to Sell?

Key Points

• KindlyMD's stock price fell by 33.4% to around $5.38, with trading volume dropping 53% from average levels.
• Despite the decline, Maxim Group initiated coverage with a "buy" rating and an $8.00 price target for the company.
• The company reported a quarterly loss of ($0.34) earnings per share with a negative net margin of 244%.

Shares of KindlyMD, Inc. (NASDAQ:NAKA - Get Free Report) fell 33.4% on Wednesday . The stock traded as low as $5.22 and last traded at $5.38. 1,432,916 shares were traded during mid-day trading, a decline of 53% from the average session volume of 3,066,629 shares. The stock had previously closed at $8.08.

Analysts Set New Price Targets

Separately, Maxim Group began coverage on KindlyMD in a research report on Wednesday, September 3rd. They issued a "buy" rating and a $8.00 target price on the stock. One equities research analyst has rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $8.00.

KindlyMD Price Performance

The stock has a 50-day moving average price of $9.16. The stock has a market capitalization of $466.39 million, a P/E ratio of -1.44 and a beta of 33.96.

KindlyMD (NASDAQ:NAKA - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported ($0.34) EPS for the quarter. The company had revenue of $0.41 million for the quarter. KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.